Wayne State University

AIM HIGHER

Technology Commercialization

A Diagnostic Marker for Matrix Metalloprotease (MMP)-2 and -9 Activity in Cancer Tissue

<- Return to Search Page

Categories
Biotechnology, Diagnostics
Summary
This invention is a method for the identification of MMP enzyme activity in tissue. MMPs are involved in tumor progression and therefore are targets for anti-cancer drug therapies. However, most drug therapies directed at inhibition of MMPs have failed, in part, because there is no reliable biomarker to determine MMP activity in tissue. This invention provides a reliable diagnostic tool to monitor MMP activity for clinical trials of MMP inhibitors.
File number
07-858
Data
Data is available upon completion of a confidentiality agreement.
Contact
Randy Ramharack Technology Licensing Manager Phone: 313-577-5541 Fax : 313-577-2814 randy.ramharack@wayne.edu